Thank you for supporting journalism at your local newspaper. This article is available exclusively for our subscribers, who help fund our work at Navarre Press.
News
UF researchers find ADHD drug does not heighten suicide risk despite FDA warning
For more than a decade, a black box warning from the Food and Drug Administration has accompanied the ADHD drug atomoxetine cautioning users of an increased risk of suicidal thoughts. But University of Florida College of Pharmacy researchers found no evidence that children taking atomoxetine were at an increased risk of suicide or suicide attempts.
The remainder of this article is available only for our website subscribers, who help fund our mission of keeping you updated on news you want and need to know. You can become a subscriber for as little as $5.67 a month.
